Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
European Journal of Cancer (Oxford, England : 1990)|June 16, 2004
Abnormal Fhit protein expression and high frequency of microsatellite instability in sporadic colorectal cancerLeopoldo Sarli, Lorena Bottarelli, Cinzia Azzoni, et al.
Surgical Oncology|November 25, 2006
Loss of p27 expression and microsatellite instability in sporadic colorectal cancerLeopoldo Sarli, Lorena Bottarelli, Cinzia Azzoni, et al.
Cancers|November 13, 2021
Monitoring cfDNA in Plasma and in Other Liquid Biopsies of Advanced EGFR Mutated NSCLC Patients: A Pilot Study and a Review of the LiteratureMichela Verzè, Roberta Minari, Letizia Gnetti, et al.
Oncology Reports|October 4, 2019
High levels of Notch intracellular cleaved domain are associated with stemness and reduced bevacizumab efficacy in patients with advanced colon cancerFrancesca Negri, Cecilia Bozzetti, Giuseppe Pedrazzi, et al.
Lung Cancer (Amsterdam, Netherlands)|April 28, 2019
From the beginning to resistance: Study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLCPaola Bordi, Marzia Del Re, Roberta Minari, et al.
JTO Clinical and Research Reports|February 24, 2022
YES1 and MYC Amplifications as Synergistic Resistance Mechanisms to Different Generation ALK Tyrosine Kinase Inhibitors in Advanced NSCLC: Brief Report of Clinical and Preclinical ProofsRoberta Minari, Samuel Valentini, Denise Madeddu, et al.
Frontiers in Oncology|March 17, 2023
Notch-Jagged1 signaling and response to bevacizumab therapy in advanced colorectal cancer: A glance to radiomics or back to physiopathology?Francesca Negri, Lorena Bottarelli, Giuseppe Pedrazzi, et al.
The Journal of Liquid Biopsy|March 3, 2025
NGS detection of gene rearrangements and METexon14 mutations in liquid biopsy of advanced NSCLC patients: A study of two Italian centersMichela Verzè, Andrea Boscolo Bragadin, Roberta Minari, et al.
Future Oncology (London, England)|November 10, 2015
Strong Notch activation hinders bevacizumab efficacy in advanced colorectal cancerFrancesca V Negri, Pellegrino Crafa, Giuseppe Pedrazzi, et al.
Immunotherapy|August 20, 2025
Prognostic immunoinflammatory and transcriptomic profiles in patients with pleural mesothelioma undergoing immunotherapyGiulia Mazzaschi, Roberto Rosati, Simona D'Agnelli, et al.
Pageof 6